FDA establishment 3016877633, India. Every inspection FDA has posted for the site, with its outcome and cited regulations, and the shipments FDA refused at the border.
FDA has posted no inspections for this site.
| Product | Charges | Latest |
|---|---|---|
| AMOXICILLIN TRIHYDRATE (PENICILLIN, SYNTHETICALLY PRODUCED)Drugs · 56BCY03 | Oct 23, 2026 | |
| KETOCONAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC)Drugs · 61WDY47 | Oct 23, 2026 | |
| URSODIOL (CHOLINERGIC)Drugs · 63NCY25 | Sep 24, 2026 | |
| DICLOFENAC SODIUM (ANTI-INFLAMMATORY)Drugs · 62GDA18 | Sep 14, 2026 | |
| NAPROXEN SODIUM (ANTI-INFLAMMATORY)Drugs · 62GAA50 | Sep 14, 2026 | |
| POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL)Drugs · 62FAY34 | Apr 17, 2026 | |
| CAMPHOR (ANTI-PRURITIC)Drugs · 62MAY01 | Apr 17, 2026 | |
| A-FUNGAL N.E.C.Drugs · 61WDO99 | Apr 14, 2025 | |
| ANTI-BACTERIAL, N.E.C.Drugs · 61HDY99 | Aug 19, 2024 | |
| NEOMYCIN SULFATE (AMINOGLYCOSIDES)Drugs · 56DCA41 | May 31, 2024 |
An FEI (FDA Establishment Identifier) names one physical site. Inspections, outcomes and citations come from FDA's Data Dashboard; FDA posts citations only for some inspections. A contract site can make products for many companies, so the company shown is the one FDA lists as the site's firm. FDA Data Dashboard and warning letters